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During Drosophila development, cells with elevated
levels of the Myc oncoprotein grow faster than, and
induce cell death in, nearby wild-type cells, suggesting
how inappropriate Myc over-expression provides cells
with a competitive advantage that can lead to cancer. 
Those of us who work on Drosophila are often asked
by scientists and lay people alike whether flies ‘get
cancer’. The answer depends on what you mean by
cancer. Certainly, flies do not get cancer the disease
that kills so many people and for which so much
research is devoted, but fly cells can display many of
the cell biological properties that human cancer cells
do, including lack of cell polarity, inappropriate
proliferation and metastasis [1–3]. At the basis of this
is conservation of proteins at the heart of regulatory
networks that go awry in cancer, such as pRB, p53,
and many oncogene products [4]. Included in the latter
group is the Myc transcription factor, which controls
the expression of a great many genes involved in cell
growth and proliferation [5]. Myc over-expression
occurs in many human cancers and often correlates
with highly aggressive tumors. Two new studies [6,7]
have used the powerful genetic tools of Drosophila to
suggest a way that tumor cells with inappropriately ele-
vated levels of Myc might acquire a significant growth
advantage over neighboring wild-type cells. 
The expression profile of Myc is consistent with a
role in promoting growth and proliferation. Myc expres-
sion is high in embryogenesis and in rapidly dividing
tissues, and low in quiescent and differentiating cells.
Furthermore, Myc expression is directly induced in
response to mitogenic stimuli, suggesting that it acts
early in growth regulatory networks. Myc interacts with
Max and functions as both a transcriptional activator
and a repressor [8–10]. Myc–Max heterodimers bind
DNA and recruit chromatin modifying factors which
influence the rate of transcription of target genes.
Growth-promoting targets of Myc–Max include cell-
cycle regulators and ribosomal protein genes, sug-
gesting that Myc exerts its effect by increasing both
cell division rates and biosynthetic capacity.
A phenomenon known as cell competition has been
described in Drosophila whereby cells with reduced
growth rates, typically achieved by reducing the dose of
a ribosomal protein gene, are eliminated via apoptosis
from developing tissues, but only if they are situated
among cells with higher growth rates [11–14]. The new
studies [6,7] show that such cell competition can be
recapitulated by juxtaposing groups of cells with differ-
ent levels of Myc expression. An important feature of
both studies is that slower-growing cell populations
with a wild-type level of Myc can be out-competed by
nearby cells over-expressing Myc, resulting in their
under-representation in the tissue (Figure 1). Further-
more, this under-representation does not occur simply
because the Myc over-expressing cells grow faster, but
because the faster-growing cells actively eliminate their
slower-growing neighbors by inducing their apoptosis.
This non-cell-autonomous response to Myc over-
expression is different from Myc’s previously reported
ability to induce apoptosis cell-autonomously [5,15].
The first clue that Myc may be involved in cell com-
petition came from the observation that clones of Myc
mutant cells grow poorly and are eliminated from the
epithelial layer of the Drosophila wing imaginal disc
[16]. Moreno and Basler [6] asked if this was the result
of the absolute or relative levels of Myc in these cells.
They generated genetically mosaic flies by two inde-
pendent schemes to create situations in which groups
of cells (clones) with normal Myc levels were posi-
tioned next to clones expressing higher Myc levels. In
one case, Myc levels were increased by using a gene
duplication, and in the other it was done by using a
heterologous promoter. 
In both cases, the clones expressing less Myc were
smaller and were out-competed by the cells with higher
Myc expression. In an elegant genetic cross to create
cells that over-expressed Myc and simultaneously
carried a mutation in a ribosomal protein gene, they
demonstrated that this ability to out-compete required
the full biosynthetic capacity of the Myc over-express-
ing cells. The cell competition was shown to be the
result of JNK-mediated apoptosis in cells with lower
Myc levels. Finally, Moreno and Basler [6] demon-
strated that the out-competed cells had reduced levels
of Dpp signaling, suggesting that competition for a
limited supply of growth or survival factors may be at
the root of the cell competition mechanism.
In the second study, de la Cova et al. [7] devised a
clever ‘three clone assay’ in which three groups of cells
with different and phenotypically distinguishable geno-
types were created simultaneously, allowing for direct
measurements and comparisons of growth rates
between different groups of cells within a single devel-
oping tissue, the wing disc (Figure 1). Importantly, two
of these clones, one over-expressing Myc and the other
with a wild-type level of Myc, were generated from the
same mitotic recombination event and developed in
close proximity to one another. The third clone, also
expressing normal Myc levels, was generated indepen-
dently from the sibling clones and served as a neutral
control for growth rate. The Myc over-expressing clone
grew to a larger size than both the sibling and neutral
clones. Moreover, the sibling clone adjacent to the Myc
over-expressing clone was always smaller than the
neutral clones generated at a distance from the sibling
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pair, suggesting that the Myc over-expressing clones
impeded the growth of sibling clones (Figure 1).
Consistent with this inference, neutral clones located
close to Myc over-expressing clones were smaller than
neutral clones located far from Myc over-expressing
clones. Again, this ability of Myc-over-expressing cells
to out-compete their neighbors was due to the induc-
tion of apoptosis in the neighboring cells, in addition to
their having an overall faster rate of growth. Interest-
ingly, de la Cova et al. [7] suggest that cell competition
via apoptosis plays a role in regulating normal organ
size. This is because in Myc mosaic wing discs —
those with a mixture of cells expressing different
amounts of Myc — the cells with elevated Myc elimi-
nate their lower expressing neighbors, always produc-
ing wings of normal size [7]. In contrast, when Myc was
ubiquitiously over-expressed or when apoptosis was
suppressed in Myc over-expressing mosaic wing
discs, competition did not occur and larger than
normal wings were produced [7].
These studies [6,7] show that Myc has a role in the
regulation of cell proliferation beyond its ability to
induce transcription of growth-promoting genes. Cells
with high levels of Myc expression can act as super-
competitors that are capable of both out-growing and
inducing death in nearby cells with lower Myc levels.
Although the mechanism of apoptotic induction is
unclear, it involves the activation of genes that are
known to trigger apoptosis in Drosophila cells, such as
hid [7]. Super-competition appears not to be a general
property of a relative increase in growth rate, because
the activation of other growth-promoting pathways did
not cause apoptosis in neighboring cells [7]. 
These observations, together with the well-
established evidence that Myc plays a prominent role in
the induction of growth-promoting gene expression,
specifically the ribosomal protein genes, suggest a
mechanism by which deregulated Myc expression can
initiate tumor formation. Oncogenic mutations that lead
to increased Myc expression [17–20] enable cells to
increase their biosynthetic capacity and clonally
expand faster than their wild-type neighbors, while
simultaneously inducing cell death in those wild-type
cells. This could allow cells with an inappropriately high
level of Myc to become tumorigenic by rapidly over-
populating a tissue while readily acquiring secondary
oncogenic lesions. 
As these interesting experiments have revealed novel
functions for a widely studied mammalian oncogene,
we would like to point out that the powerful genetic
tools of Drosophila provided a unique opportunity to
create situations in vivo in which cells with wild-type
Myc levels were juxtaposed to ones over-expressing
Myc. It is difficult to imagine how this super-competitor
function of Myc could have otherwise been discovered.
So even though flies do not actually get the disease
that kills thousands of people every year, they can 
still tell us something important about the biology 
of carcinogenesis.
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Figure 1. High levels of Myc result in a competitive advantage.
A diagram of a Drosophila wing disc, which is a single layer of
undifferentiated epithelial cells. In the ‘three clone’ assay [7], a
mitotic recombination event induced early during wing disc
development creates two clones of cells, one with wild-type
levels of Myc (red) juxtaposed to one expressing higher levels
of Myc (green). A separate recombination event elsewhere in
the disc generates a neutral clone (blue), also marked and
expressing a wild-type level of Myc. As the clones were
induced simultaneously, the growth rates — clone size at the
end of the experiment — of each group of cells can be com-
pared. The Myc over-expressing clone (green) is larger than the
neutral clone (blue), indicating that increasing the level of Myc
increases growth rate. Clones expressing a wild-type level of
Myc (red) adjacent to Myc over-expressing clones are the
smallest, indicating that Myc over-expression is capable of
impeding the growth of nearby cells. This occurs because the
Myc over-expressing cells induce apoptosis in neighboring
cells with a lower level of Myc. Thus, Myc over-expression
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